RLMD

NASDAQStock

Relmada Therapeutics, Inc.

$6.03-0.13 (-2.03%)

52-Week Range

$0.25

$7.17

Key Stats

Market Cap

441.8M

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.73

Volume

393.9K

Avg Volume

3.9M

Performance

+53.75%

+41.06%

+268.26%

YTD

+40.73%

+2162.69%

+118.86%

-82.55%

Price Chart

ETF Exposure

RLMD is held by 4 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
PSIL	AdvisorShares Psychedelics ETF	7.15%	338,872	$1.5M	$20.4M	1.84%
PQSG	PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF	0.16%	721	$21K	$13.0M	N/A
STSB	iShares Factors US Small Blend Style ETF	0.03%	63	$2K	$7.3M	0.35%
VXF	Vanguard Extended Market ETF	0.00%	798,968	$2.8M	$84.10B	0.05%

About RLMD ETF Exposure

Relmada Therapeutics, Inc. (RLMD) is held by 4 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 441.8M, RLMD is a widely held institutional stock. The stock currently trades at $6.03. Investors can gain exposure to RLMD through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RLMD, sorted by portfolio weight.